Clinical Trials Logo

Intestinal Diseases clinical trials

View clinical trials related to Intestinal Diseases.

Filter by:

NCT ID: NCT03778918 Recruiting - Clinical trials for Inflammatory Bowel Diseases

The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group

Start date: August 1, 2016
Phase:
Study type: Observational [Patient Registry]

The aims of this study is to investigate a blood-based biomarker that can replace endoscopy in patients with inflammatory bowel disease. For this purpose, blood sample of patients wiht inflammatory bowel disease (ulcerative colitis, Crohn 's disease) was collected at the same time the endoscopy is performed, stored after centrifugation, and analyzed accordingly. Selected biomarkers from the blood sample were investigated to compare those of patients with inflammatory bowel disease and those of general controls. Males and females over the age of 19 participated in the study and are excluded if they have chronic kidney disease or blood clotting disease. The outcome is a find of a blood-based biomarker that best reflects a disease activity.

NCT ID: NCT03774329 Recruiting - Ulcerative Colitis Clinical Trials

Impact of a Physical Activity Program on Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease

PROPHYSICOS
Start date: March 2, 2020
Phase: N/A
Study type: Interventional

Muscle and physical activity play an important role in in growth, development and bone health in healthy children, especially during puberty. Children with inflammatory bowel disease (IBD) have lower level and intensity of physical compared to a control group. Several studies have shown that children with IBD have a lower bone mineral density (BMD) than general population, due to risk factors such as corticosteroid use, disease intensity, inflammation, malnutrition and a vitamin D deficiency. This low BMD is associated with an increased risk of fracture. A recent observational study found a positive and significant correlation between BMD in IBD patients and time spent in moderate to vigorous physical activity for one week (unpublished data).The present study aims to show a benefit of an adapted physical activity program on BMD in children and adolescents with IBD.

NCT ID: NCT03771508 Recruiting - Clinical trials for Small Intestine Cancer

Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)

SODA
Start date: December 13, 2018
Phase:
Study type: Observational

Observational, Multicenter, Post-market, Minimal risk, Prospective data collection of PillCam SB3 videos (including PillCam reports) and raw data files and optional collection of Eneteroscopy reports

NCT ID: NCT03744130 Recruiting - Clinical trials for Inflammatory Bowel Disease

Contrast-enhanced Bowel Ultrasound in Making a Diagnosis and Follow-up of Patients With Inflammatory Bowel Disease

Start date: January 10, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy of SonoVue® in participants with Crohn's disease and ulcerative colitis to various aspects including type of Inflammatory Bowel Disease, disease activity, the need for surgical treatment.

NCT ID: NCT03719209 Recruiting - Clinical trials for Inflammatory Bowel Diseases

Using Virtual Reality for Patients With Gastrointestinal Disease

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

The primary aim of this study is to evaluate the effect and impact of a technology which creates a virtual reality (VR), personalized representation of a patient's endoscopic findings in comparison our standard practice (SP). Our study will compare the level of knowledge, understanding and satisfaction the patient and family have between those receiving SP and those receiving both SP and VR.

NCT ID: NCT03715673 Recruiting - Clinical trials for Inflammatory Bowel Diseases

Von Willebrand Antigen and Activity as Novel Biomarkers of Hemostasis in Inflammatory Bowel Disease

Start date: October 1, 2019
Phase:
Study type: Observational

The investigators are going to study von Willebrand antigen and activity levels in patients with inflammatory bowel disease. The study will be on 46 patients who were diagnosed with inflammatory bowel disease mainly ulcerative colitis and Crohn's disease divided into two arms; group A will include 23 cases with active IBD(cases)status and group B will include 23 cases with inactive IBD status(control) to compare the vWF antigen and activity ( expected to be higher in active disease group. The investigators will follow all of the patients for any arterial or venous thrombosis to evaluate IBD as a risk factor of thrombosis, on the other hand, they are looking to detect cases of acquired von Willebrand syndrome in some cases with bleeding that not explained by the inflammatory bowel disease status. The aim of the work: 1. Assessment of VWF antigen in patients with inflammatory bowel disease and correlate it to disease activity. 2. Evaluation of VWF antigen as a risk factor for thrombosis in inflammatory bowel disease patients. 3. Detection of acquired von Willebrand disease in inflammatory bowel disease.

NCT ID: NCT03698500 Recruiting - Ulcerative Colitis Clinical Trials

Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease

Start date: January 2017
Phase: N/A
Study type: Interventional

The aim of this study is to assess the ability of miR-320a and other specific microRNAs to follow the disease course in patients with Crohn`s disease (CD) and ulcerative colitis (UC), and to distinguish both entities, infectious colitis and healthy controls. Furthermore, the accuracy of miRNA-320a to distinguish CD or UC from irritable bowel syndrome (IBS) should be evaluated . The study is designed as a single center non-randomised prospective trial.

NCT ID: NCT03615287 Recruiting - Clinical trials for Inflammatory Bowel Diseases

Assessing Cardiovascular Dysfunction Pre- & Post-treatment in Inflammatory Bowel Diseases

Start date: January 26, 2018
Phase:
Study type: Observational

The aim of this study is to compare medical and surgery treatment in IBD patients and healthy controls, by assessing the endothelial and cardiac function and the inflammation status.

NCT ID: NCT03589183 Recruiting - Ulcerative Colitis Clinical Trials

Gut Microbiome in Inflammatory Bowel Disease

Start date: April 1, 2018
Phase:
Study type: Observational

Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity. In this background, the investigators have composed a prospective cohort of Korean IBD patients in a large academic referral IBD center. Using an integrated multi-omics bioinformatic analysis, the investigators aim to explore gut microbial signatures along with distinct clinical/genetic features, and their potential interplay in patients with IBD.

NCT ID: NCT03576027 Recruiting - Clinical trials for Inflammatory Bowel Diseases

Hyperbaric Oxygen Therapy in Children With Inflammatory Bowel Diseases

Start date: May 21, 2018
Phase: N/A
Study type: Interventional

The study assesses the effectiveness of hyperbaric oxygen therapy in the treatment of inflammatory bowel disease in children.